RPHM Live signals | Maximize Profits with Getagraph.com

BUY 116203 min ago

@ $1.715

Issued: 9 Feb 2024 @ 11:54

Return: -2.62%

Previous signal: Feb 9 - 10:42

Previous signal: Sell

Return: 0.42 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 16:00):

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases...

Stats
Today's Volume	155 523
Average Volume	190 059
Market Cap	55.63M
EPS	$0 ( 2024-03-25 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.00400 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-28	Hall Ashley	Sell	15 625	Stock option (right to buy)
2023-08-28	Hall Ashley	Buy	15 625	Common Stock
2023-08-28	Hall Ashley	Sell	15 625	Common Stock
2023-07-26	Grey Michael G	Sell	50 000	Common Stock
2023-06-23	Novo Holdings A/s	Sell	100 000	Common Stock

INSIDER POWER
49.63
Last 95 transactions
Buy: 16 929 845 \| Sell: 55 923 583

Volume Correlation

Long: 0.05 (neutral)

Short: -0.45 (neutral)

Signal:(65.437) Neutral

Reneo Pharmaceuticals, Correlation

10 Most Positive Correlations
PYXS	0.915
XPON	0.867
SGTX	0.851
XOG	0.84
SGEN	0.839
HJLI	0.828
SATS	0.827
NTRA	0.822
BTBD	0.814
OTTR	0.813

10 Most Negative Correlations
ALT	-0.872
LMRKN	-0.824
ISTR	-0.815
HOUR	-0.813
BSBK	-0.812
MYFW	-0.807
RNRG	-0.806
CFFN	-0.805
VWE	-0.805
AMRB	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Reneo Pharmaceuticals, Correlation - Currency/Commodity

0.08
( neutral )

0.00
( neutral )

-0.18
( neutral )

0.17
( neutral )

Reneo Pharmaceuticals, Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-529 000 (0.00 %)
EPS:	$-2.04

FY	2022
Revenue:	$0
Gross Profit:	$-529 000 (0.00 %)
EPS:	$-2.04

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-5.11

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.50

Financial Reports:

No articles found.

Reneo Pharmaceuticals,

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.